General Information of Drug Off-Target (DOT) (ID: OTCN4IQZ)

DOT Name tRNA wybutosine-synthesizing protein 2 homolog (TRMT12)
Synonyms tRNA-yW-synthesizing protein 2; EC 2.5.1.114; tRNA(Phe; 4-demethylwyosine(37)-C(7)) aminocarboxypropyltransferase
Gene Name TRMT12
Related Disease
Breast cancer ( )
Breast carcinoma ( )
Breast neoplasm ( )
Neoplasm ( )
UniProt ID
TYW2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
2.5.1.114
Pfam ID
PF02475
Sequence
MRENVVVSNMERESGKPVAVVAVVTEPWFTQRYREYLQRQKLFDTQHRVEKMPDGSVALP
VLGETLPEQHLQELRNRVAPGSPCMLTQLPDPVPSKRAQGCSPAQKLCLEVSRWVEGRGV
KWSAELEADLPRSWQRHGNLLLLSEDCFQAKQWKNLGPELWETVALALGVQRLAKRGRVS
PDGTRTPAVTLLLGDHGWVEHVDNGIRYKFDVTQCMFSFGNITEKLRVASLSCAGEVLVD
LYAGIGYFTLPFLVHAGAAFVHACEWNPHAVVALRNNLEINGVADRCQIHFGDNRKLKLS
NIADRVILGLIPSSEEGWPIACQVLRQDAGGILHIHQNVESFPGKNLQALGVSKVEKEHW
LYPQQITTNQWKNGATRDSRGKMLSPATKPEWQRWAESAETRIATLLQQVHGKPWKTQIL
HIQPVKSYAPHVDHIVLDLECCPCPSVG
Function
S-adenosyl-L-methionine-dependent transferase that acts as a component of the wybutosine biosynthesis pathway. Wybutosine is a hyper modified guanosine with a tricyclic base found at the 3'-position adjacent to the anticodon of eukaryotic phenylalanine tRNA. Catalyzes the transfer of the alpha-amino-alpha-carboxypropyl (acp) group from S-adenosyl-L-methionine to the C-7 position of 4-demethylwyosine (imG-14) to produce wybutosine-86.
Reactome Pathway
Synthesis of wybutosine at G37 of tRNA(Phe) (R-HSA-6782861 )

Molecular Interaction Atlas (MIA) of This DOT

4 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Breast cancer DIS7DPX1 Strong Altered Expression [1]
Breast carcinoma DIS2UE88 Strong Altered Expression [1]
Breast neoplasm DISNGJLM Strong Altered Expression [1]
Neoplasm DISZKGEW Strong Altered Expression [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
6 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of tRNA wybutosine-synthesizing protein 2 homolog (TRMT12). [2]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of tRNA wybutosine-synthesizing protein 2 homolog (TRMT12). [3]
Sodium lauryl sulfate DMLJ634 Approved Sodium lauryl sulfate decreases the expression of tRNA wybutosine-synthesizing protein 2 homolog (TRMT12). [5]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of tRNA wybutosine-synthesizing protein 2 homolog (TRMT12). [6]
Tocopherol DMBIJZ6 Phase 2 Tocopherol increases the expression of tRNA wybutosine-synthesizing protein 2 homolog (TRMT12). [7]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of tRNA wybutosine-synthesizing protein 2 homolog (TRMT12). [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of tRNA wybutosine-synthesizing protein 2 homolog (TRMT12). [4]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of tRNA wybutosine-synthesizing protein 2 homolog (TRMT12). [8]
------------------------------------------------------------------------------------

References

1 Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer.Genes Chromosomes Cancer. 2007 Jul;46(7):694-707. doi: 10.1002/gcc.20454.
2 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
3 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
4 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
5 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
6 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
7 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
8 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
9 Gene expression changes in primary human nasal epithelial cells exposed to formaldehyde in vitro. Toxicol Lett. 2010 Oct 5;198(2):289-95.